Search Orphan Drug Designations and Approvals
-
Generic Name: | Dantrolene sodium |
---|---|
Date Designated: | 12/14/1987 |
Orphan Designation: | Treatment of the neuroleptic malignant syndrome. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Norwich Eaton Pharmaceuticals P.O. Box 191 Norwich, New York 13815 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-